Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Trends Endocrinol Metab. 2018 Nov 29;30(1):54–65. doi: 10.1016/j.tem.2018.11.001

Figure 2.

Figure 2.

Polycystic Ovary Syndrome (PCOS) Is Correlated with an Increased Risk of Developing Reproductive and Metabolic Dysregulation. PCOS is diagnosed using the Rotterdam Consensus Criteria that require two out of three of the following criteria: hyperandrogenism (HA), oligo- or amenorrhea, and polycystic ovaries. Women diagnosed with PCOS have an increased risk of infertility, miscarriage, and pregnancy complications. Women with PCOS that have HA also have metabolic dysregulation, including obesity, insulin resistance, and dyslipidemia that increases their risk for type 2 diabetes, hypertension, and non-alcoholic fatty liver disease (NAFLD).